Vaccines

The COVID-19 landscape has continued to evolve during the 2 years since it was first detected in the United States, and research continues to explore how both the virus and its multiple vaccines affect people in different populations.

BOSTON — In this video from the National Kidney Foundation Spring Clinical Meetings, Joseph A. Vassalotti, MD talks about the first live conference of the NKF in 2 years, amid thoughts on patients who died during the COVID-19 pandemic.

The Coalition for Epidemic Preparedness Innovations, or CEPI, launched a multi-billion dollar plan to accelerate the development and production of vaccines during the next pandemic, with a goal of making them available in just 100 days.

Compared with unvaccinated patients on maintenance dialysis, those with one to two vaccines against COVID-19 showed better immunity to infection and severe illness.

In its latest public campaign to encourage parents to vaccinate their children, the AAP launched a new series of videos that address common questions parents have about childhood vaccines.

After more than 40 years, a vaccine against HIV “remains elusive” because of several significant barriers, including the complexity of the virus and shifts in focus to other infectious diseases, like COVID-19, an expert said.

A new study reinforced that influenza vaccination protects children from serious illness even when vaccines are a poor match for circulating viruses.

Data from a survey representing more than 7,500 parents showed that about one-quarter were hesitant to get their child vaccinated.

In a study of kidney transplant patients who showed no immune response to two SARS-CoV-2 vaccines, 39% developed antibodies within 4 weeks of a third dose.

The FDA granted fast track designation to UV1 in combination with checkpoint inhibitor therapy for treatment of unresectable or metastatic melanoma.